Skip to content
What is VVA/GSM?
Please take a few minutes to answer this brief CONFIDENTIAL survey.
Your feedback will be valuable in developing new products to meet menopausal women's health needs.
1.
Are you currently menopausal (have not had a menstrual period for 12 consecutive months) or postmenopausal (including surgically menopausal)?
Yes
No
*
2.
Are you experiencing any of the following symptoms? Check all that apply.
(Required.)
Vaginal irritation, dryness
Vaginal itching or burning
Difficulty and/or pain with intercourse
Frequency of urination and urination urges
Incontinence
Increase in urinary tract infections
Not experiencing any symptoms
*
3.
Are you using any of the following treatments to alleviate any of the above symptoms? Check all that apply.
(Required.)
Vaginal estrogen (e.g., Estrace or Premarin cream, Estring ring, Vagifem tablet suppository, IMVEXXY)
Intrarosa
Oral SERM (Osphena)
Non-prescription over-the counter vaginal lubrication and/or anti-itch products
None, but have symptoms
None, not experiencing any symptoms
Other (please specify)
*
4.
VulvoVaginal Atrophy (VVA) is a condition that results in the thinning of the walls of the vagina caused by decreased estrogen levels. For many women vaginal atrophy not only makes intercourse painful but also can lead to distressing urinary symptoms.
Have any of your doctors ever initiated a conversation about VVA, symptoms or treatment options?
(Required.)
No, my doctor has never initiated a conversation
Yes, my doctor started a conversation about VVA, symptoms and treatment
No, but I initiated the discussion about my symptoms
If Yes, please specify the type of doctor (primary care, gynecologist, oncologist, etc)
*
5.
Low dose, vaginally inserted estrogens are available to treat VVA. Are you willing to use a vaginal estrogen?
(Required.)
Yes (Please continue to question #7)
No
6.
If you are not willing to use a vaginal estrogen, why not? Check all that apply.
My doctor told me not to take estrogen
I heard estrogen can increase my risk of breast cancer
I don't like taking prescription drugs
My symptoms aren't severe enough
Other (please specify)
*
7.
These vaginally inserted estrogens (Estrace or Premarin cream, Estring ring, Vagifem tablet suppository, IMVEXXY, Intrarosa) carry a warning label for endometrial and breast cancer, blood clots and dementia.
Knowing that vaginal estrogen products contain this warning, would you use them?
(Required.)
Yes
No
Not Sure
If not sure, please explain.
*
8.
There is another class of products which is NON-estrogen. This class is known as Selective Estrogen Receptor Modulators(SERM). Some SERMS such as Nolvadex (tamoxifen) and Evista (raloxifene) in their oral form have been proven to reduce the risk of breast cancer. Some SERMS are being developed to treat VVA.
The expected profile for a proposed vaginally delivered VVA SERM is:
Effective in treating VVA and its symptoms
No warnings on label for increased risk of breast cancer or endometrial cancer
If you are experiencing VVA symptoms would you take or switch to this product when available?
(Required.)
Yes
No
Not Sure
If not sure, please explain.
9.
If you were willing to use a vaginal insert, which dosing would you prefer?
1x per week
2x per week
Daily
*
10.
Are you a breast cancer survivor or at high risk? Check all that apply.
(Required.)
Yes, I am a breast cancer survivor (includes DCIS)
Yes, I have family history or genetic predisposition of breast cancer
Yes, I have other conditions that increase my risk
No, I am not a breast cancer survivor nor am I high risk
Thank you for your time. If there is any other information you would like to share, please add it here.